1. Effect of low-level light therapy before radiotherapy in oral squamous cell carcinoma: An in vitro study.
- Author
-
Tabosa ATL, Souza MG, de Jesus SF, Rocha DF, Queiroz LDRP, Santos EM, Guimarães VHD, Andrade LAA, Santos SH, de Paula AMB, de Souza PEN, Farias LC, and Guimarães ALS
- Subjects
- Humans, Squamous Cell Carcinoma of Head and Neck radiotherapy, Squamous Cell Carcinoma of Head and Neck etiology, Reactive Oxygen Species, Mouth Neoplasms radiotherapy, Mouth Neoplasms pathology, Carcinoma, Squamous Cell radiotherapy, Carcinoma, Squamous Cell pathology, Low-Level Light Therapy methods, Head and Neck Neoplasms radiotherapy
- Abstract
Radiation therapy for head and neck squamous cell carcinoma (HNSCC) is associated with several complications. Although photobiomodulation (PBM) has radioprotective effects in normal tissue, it could also enhance the growth of neoplastic cells. Thus, the present study aimed to investigate the cellular response of oral squamous cell carcinoma with pre-exposure to low-level phototherapy before radiotherapy. SCC9, Cal-27, A431, and HaCaT cell lines were subjected to low-level light therapy and radiotherapy. The cells were treated with a single energy density (300 J/cm
2 ) of a light-emitting diode (660 nm) prior to ionizing radiation at different doses (0, 2, 4, and 6 Gy). After 24 h, wound scratch, proliferation, clonogenic cell survival, cell death, and reactive oxygen species (ROS) analyses were performed to evaluate cell response. The cell lines pre-exposed to PBM at the analyzed dosage were radiosensitive. The treatment significantly reduced cell proliferation and clonogenic cell survival. Migration and cell death assays also revealed positive results, with the treatment group showing lower rate of migration and higher cell death than did the control group. Moreover, PBM effectively increased the intracellular levels of ROS. PBM at 300 J/cm2 is a promising radiosensitizing modality to reduce the radiation dose and avoid the intolerable side effects of radiotherapy for HNSCC, thus increasing the probability of successful treatment. However, further studies are needed to support and confirm the results., (© 2022. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.)- Published
- 2022
- Full Text
- View/download PDF